Absence of type I estrogen receptors in choroidal melanoma: Analysis of Collaborative Ocular Melanoma Study (COMS) eyes

Citation
Rj. Grostern et al., Absence of type I estrogen receptors in choroidal melanoma: Analysis of Collaborative Ocular Melanoma Study (COMS) eyes, AM J OPHTH, 131(6), 2001, pp. 788-791
Citations number
37
Categorie Soggetti
Optalmology,"da verificare
Journal title
AMERICAN JOURNAL OF OPHTHALMOLOGY
ISSN journal
00029394 → ACNP
Volume
131
Issue
6
Year of publication
2001
Pages
788 - 791
Database
ISI
SICI code
0002-9394(200106)131:6<788:AOTIER>2.0.ZU;2-U
Abstract
PURPOSE: To evaluate choroidal melanomas in enucleated eyes for the presenc e of type I estrogen receptors. METHODS: Fourteen consecutive eyes with large choroidal melanomas (defined as >16-mm basal diameter and >8 mm thickness) from 14 patients (eight women and six men with a mean age of 57 years; range, 25-74 years) enucleated in accordance with the Collaborative Ocular Melanoma Study (COMS) protocol we re investigated. Immunohistochemical techniques were employed to label the choroidal melanomas for the presence of type I estrogen receptors. Each spe cimen was then evaluated in a masked fashion by an experienced ophthalmic p athologist for positive nuclear staining. RESULTS: No tumors showed immunohistochemical evidence of a type I estrogen receptor. CONCLUSION: Type I estrogen receptors are not present in choroidal melanoma . Estrogens are not likely to influence choroidal melanoma growth through t raditional receptors. (Am J Ophthalmol 2001;131:788-791. (C) 2001 by Elsevi er Science Inc. All rights reserved.).